Dataset Information

Joint epitope selection and spacer design for string-of-beads vaccines.

ABSTRACT:

Motivation

Conceptually, epitope-based vaccine design poses two distinct problems: (i) selecting the best epitopes to elicit the strongest possible immune response and (ii) arranging and linking them through short spacer sequences to string-of-beads vaccines, so that their recovery likelihood during antigen processing is maximized. Current state-of-the-art approaches solve this design problem sequentially. Consequently, such approaches are unable to capture the inter-dependencies between the two design steps, usually emphasizing theoretical immunogenicity over correct vaccine processing, thus resulting in vaccines with less effective immunogenicity in vivo.

Results

In this work, we present a computational approach based on linear programming, called JessEV, that solves both design steps simultaneously, allowing to weigh the selection of a set of epitopes that have great immunogenic potential against their assembly into a string-of-beads construct that provides a high chance of recovery. We conducted Monte Carlo cleavage simulations to show that a fixed set of epitopes often cannot be assembled adequately, whereas selecting epitopes to accommodate proper cleavage requirements substantially improves their recovery probability and thus the effective immunogenicity, pathogen and population coverage of the resulting vaccines by at least 2-fold.

Availability and implementation

The software and the data analyzed are available at https://github.com/SchubertLab/JessEV.

Supplementary information

Supplementary data are available at Bioinformatics online.

SUBMITTER: Dorigatti E

PROVIDER: S-EPMC7773482 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Joint epitope selection and spacer design for string-of-beads vaccines.

Dorigatti Emilio E Schubert Benjamin B

Bioinformatics (Oxford, England) 20201201 Suppl_2

<h4>Motivation</h4>Conceptually, epitope-based vaccine design poses two distinct problems: (i) selecting the best epitopes to elicit the strongest possible immune response and (ii) arranging and linking them through short spacer sequences to string-of-beads vaccines, so that their recovery likelihood during antigen processing is maximized. Current state-of-the-art approaches solve this design problem sequentially. Consequently, such approaches are unable to capture the inter-dependencies between ...[more]

PMID: 33381831

Similar Datasets

Project description:The string-matching paradigm is applied in every computer science and science branch in general. The existence of a plethora of string-matching algorithms makes it hard to choose the best one for any particular case. Expressing, measuring, and testing algorithm efficiency is a challenging task with many potential pitfalls. Algorithm efficiency can be measured based on the usage of different resources. In software engineering, algorithmic productivity is a property of an algorithm execution identified with the computational resources the algorithm consumes. Resource usage in algorithm execution could be determined, and for maximum efficiency, the goal is to minimize resource usage. Guided by the fact that standard measures of algorithm efficiency, such as execution time, directly depend on the number of executed actions. Without touching the problematics of computer power consumption or memory, which also depends on the algorithm type and the techniques used in algorithm development, we have developed a methodology which enables the researchers to choose an efficient algorithm for a specific domain. String searching algorithms efficiency is usually observed independently from the domain texts being searched. This research paper aims to present the idea that algorithm efficiency depends on the properties of searched string and properties of the texts being searched, accompanied by the theoretical analysis of the proposed approach. In the proposed methodology, algorithm efficiency is expressed through character comparison count metrics. The character comparison count metrics is a formal quantitative measure independent of algorithm implementation subtleties and computer platform differences. The model is developed for a particular problem domain by using appropriate domain data (patterns and texts) and provides for a specific domain the ranking of algorithms according to the patterns' entropy. The proposed approach is limited to on-line exact string-matching problems based on information entropy for a search pattern. Meticulous empirical testing depicts the methodology implementation and purports soundness of the methodology.

Project description:We developed an epitope selection method for the design of MHC targeting peptide vaccines. The method utilizes predictions for several clinical checkpoint filters, including binding affinity, immunogenicity, antigenicity, half-life, toxicity, IFNγ release, and instability. The accuracy of the prediction tools for these filter variables was confirmed using experimental data obtained from the Immune Epitope Database (IEDB). We also developed a graphical user interface computational tool called 'PCOptim' to assess the success of an epitope filtration method. To validate the filtration methods, we used a large data set of experimentally determined, immunogenic SARS-CoV-2 epitopes, which were obtained from a meta-analysis. The validation process proved that placing filters on individual parameters was the most effective method to select top epitopes. For a proof-of-concept, we designed epitope-based vaccine candidates for squamous cell carcinoma, selected from the top mutated epitopes of the HRAS gene. By comparing the filtered epitopes to PCOptim's output, we assessed the success of the epitope selection method. The top 15 mutations in squamous cell carcinoma resulted in 16 CD8 epitopes which passed the clinical checkpoints filters. Notably, the identified HRAS epitopes are the same as the clinical immunogenic HRAS epitope-based vaccine candidates identified by the previous studies. This indicates further validation of our filtration method. We expect a similar turn-around for the other designed HRAS epitopes as a vaccine candidate for squamous cell carcinoma. Furthermore, we obtained a world population coverage of 89.45% for the top MHC Class I epitopes and 98.55% population coverage in the absence of the IFNγ release clinical checkpoint filter. We also identified some of the predicted human epitopes to be strong binders to murine MHC molecules, which provides insight into studying their immunogenicity in preclinical models. Further investigation in murine models could warrant the application of these epitopes for treatment or prevention of squamous cell carcinoma.

Project description:Despite recent advances in therapeutic options, hepatitis C virus (HCV) remains a severe global disease burden, and a vaccine can substantially reduce its incidence. Due to its extremely high sequence variability, HCV can readily escape the immune response; thus, an effective vaccine must target conserved, functionally important epitopes. Using the structure of a broadly neutralizing antibody in complex with a conserved linear epitope from the HCV E2 envelope glycoprotein (residues 412 to 423; epitope I), we performed structure-based design of immunogens to induce antibody responses to this epitope. This resulted in epitope-based immunogens based on a cyclic defensin protein, as well as a bivalent immunogen with two copies of the epitope on the E2 surface. We solved the X-ray structure of a cyclic immunogen in complex with the HCV1 antibody and confirmed preservation of the epitope conformation and the HCV1 interface. Mice vaccinated with our designed immunogens produced robust antibody responses to epitope I, and their serum could neutralize HCV. Notably, the cyclic designs induced greater epitope-specific responses and neutralization than the native peptide epitope. Beyond successfully designing several novel HCV immunogens, this study demonstrates the principle that neutralizing anti-HCV antibodies can be induced by epitope-based, engineered vaccines and provides the basis for further efforts in structure-based design of HCV vaccines.IMPORTANCE Hepatitis C virus is a leading cause of liver disease and liver cancer, with approximately 3% of the world's population infected. To combat this virus, an effective vaccine would have distinct advantages over current therapeutic options, yet experimental vaccines have not been successful to date, due in part to the virus's high sequence variability leading to immune escape. In this study, we rationally designed several vaccine immunogens based on the structure of a conserved epitope that is the target of broadly neutralizing antibodies. In vivo results in mice indicated that these antigens elicited epitope-specific neutralizing antibodies, with various degrees of potency and breadth. These promising results suggest that a rational design approach can be used to generate an effective vaccine for this virus.

Dataset Information

Joint epitope selection and spacer design for string-of-beads vaccines.

Motivation

Results

Availability and implementation

Supplementary information

Publications

Joint epitope selection and spacer design for string-of-beads vaccines.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure